期刊文献+

全破壁灵芝孢子治疗男性更年期综合征 被引量:5

The Efficacy of Sporoderm-broken Ganoderma Spores in Treatment of Male Climacteric Syndrome
下载PDF
导出
摘要 目的 :探讨全破壁灵芝孢子治疗法对男性更年期综合征的疗效。方法 :通过对 138例诊断为男性更年期综合征病人分组 ,其中 80例作全破壁灵芝孢子胶囊治疗并对其临床症状 ,血睾酮、SOD、MDA水平及主观抑郁症状评分作观察 ,并与 5 8例病情相同的病人予安慰剂对照。结果 :治疗组的病人症状改善率为 74 .3% ,血睾酮水平 3周前后分别为 (131.5 1± 19.12 )mg/L与 (2 5 3.78± 2 1.4 5 )mg/L ,SOD水平 3周前后分别为 (10 6 8.3± 12 1.4 )U/ g·Hb与 (1178.1± 132 .6 )U/ g .Hb ,MDA水平 3周前后分别为 (7.6± 0 .8) μmol/L与 (5 .8± 0 .6 )μmol/L。抑郁症状评分各指标均有较大改善。 结论 :全破壁灵芝孢子胶囊是治疗男性更年期综合征的一种有效、安全的方法。 Objective:To investigate the efficacy of sporoderm-broken ganoderma spores in treatment of male climacteric syndrome. Methods: 138 male patients with male climacteric syndrome were randomized to received sporoderm-broken ganoderma spore capsules (n=80) and observed for changes in symptoms, serum testosterone, SOD, MDA and depression scores as compared with 58 controls on placebo. Results: Over 3 weeks, patients on sporodermo-broken ganoderma spores were improved in symptoms by 74%. Before treatment and on week 3 in the treatment group, the serum testosterone level was(131.51±19.12)mg/L and (253.78±21.45)mg/lL, SOD level was(1 068.3±121.4)U/g.Hb and(1 178.1±132.6)U/g.Hb, and MDA level was(7.6±0.8)μmol/L and (5.8±0.6)μmol/L respectively. Conclusion: sporoderm-broken ganoderma spore was effective and safe for treatment of male climateric syndrome. Scores of depression were also improved after treatment.
出处 《广州医学院学报》 2004年第1期46-48,共3页 Academic Journal of Guangzhou Medical College
关键词 全破壁灵芝孢子 男性更年期综合征 治疗 sporoderm-broken ganoderma spores male climateric syndrome treatment
  • 相关文献

参考文献8

  • 1Feldman HA,Goldstein I,Hatzichristou DG,et al,Impotence and its medical and psychosocial correloles:results of the Massachusetts Male Aging study[J]. J Urol,1994,151(1):54-61.
  • 2Hang TT. Wilhelmsen,I,. Ursin H,et al. what are the Real problems for patients with Functional Dyspepsia?[J].Sced J Gastro enterd,1995,30(2):97-100.
  • 3Vermeulen A,Steed S,luisl,McCullock DK et al:The prevalence of diabetic impotence[J]. J Clin Endocnol Metab,1972,34(4):730-735.
  • 4Bremner wj Brunner GA,Sethia K et al.Erectile dysfanction in patients with type Idiabetes mellitas[J]. J Clin Endo crinol Metab,1993,75,(1):71-77.
  • 5Vermenlen A,Dignosis of partial Andogen Deficiency in Aging Male[J]. Ann endocrinol. 2003,64(2):109-114.
  • 6Seidman SN.Walsh BT. Testosterone and depression in aging men [J].Am J Geriatr Psychiatry,1999,7(1) : 18-33.
  • 7Gooren LJG,A ten-year safety study of the oral androgen testosterone undecanoate[J].J Audrology,1994,15(3):234-235.
  • 8Raskin J G,Wagner G J, Rabkin R,Testosterone therapy for human immunodeficiency vivus-positive men with and without hypogonadism[J].J Clin psychopharmacol,1999,11(1):19-27.

同被引文献86

引证文献5

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部